"Colombia Pharmaceuticals & Healthcare Report Q3 2013" Now Available at Fast Market Research
The World Health Organization (WHO)'s recent adjustment to Colombia's historical healthcare expenditure highlights the government's efforts to contain costs and the greater-than-expected financial difficulties affecting the country's private healthcare reforms. We forecast relatively strong growth in Colombia's public healthcare spending, as the cost of healthcare provision escalates and demand increases for drugs and services under the Obligatory Health Plan (POS). The country's private healthcare sector will grow at a much lower rate, as there is no indication to show that...
View full press release